Brief: Intellia Therapeutics Q2 Net Income USD -106.634 Million
06/08/2026 12:01
BRIEF-Intellia Therapeutics Q2 Net Income USD -106.634 Million Aug 06 (Reuters) - Intellia Therapeutics Q2 collaboration revenue USD 7.659 million.
- Q2 basic EPS USD -0.8
- Q2 operating expenses USD 120.419 million
- Q2 operating income USD -112.76 million
Recent news on INTELLIA THERAPEUTICS
See all newsU.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
U.S. STOCKS ON THE MOVE-Qualcomm, Eaton, Howmet Aerospace
U.S. STOCKS ON THE MOVE-Sigma Lithium, Shake Shack, Novartis
Intellia rises after FDA grants fast-track status to its treatment for rare disease
Brief: Intellia Therapeutics Announces FDA Acceptance Of Biologics License Application With Priority Review For Lonvoguran Ziclumeran (Lonvo-Z) For Hereditary Angioedema (Hae)